Access the full text.
Sign up today, get DeepDyve free for 14 days.
F. Liotti, Narender Kumar, N. Prevete, Maria Marotta, D. Sorriento, C. Ieranò, A. Ronchi, F. Marino, S. Moretti, R. Colella, Efiso Puxeddu, S. Paladino, Y. Kano, M. Ohh, S. Scala, R. Melillo (2020)
PD-1 blockade delays tumor growth by inhibiting an intrinsic SHP2/Ras/MAPK signalling in thyroid cancer cellsJournal of Experimental & Clinical Cancer Research : CR, 40
C. Cruz, L. Tanoue, R. Matthay (2011)
Lung cancer: epidemiology, etiology, and prevention.Clinics in chest medicine, 32 4
Junli Zhang, Xiaohui Zhao, Xiaojuan Ma, Zengyan Yuan, Miao Hu (2020)
KCNQ1OT1 contributes to sorafenib resistance and programmed death-ligand-1-mediated immune escape via sponging miR-506 in hepatocellular carcinoma cellsInternational Journal of Molecular Medicine, 46
Chunyan Li, Lin Zhang, Guang-Ping Meng, Qi Wang, Xuejiao Lv, Jie Zhang, Junyao Li (2019)
Circular RNAs: pivotal molecular regulators and novel diagnostic and prognostic biomarkers in non-small cell lung cancerJournal of Cancer Research and Clinical Oncology, 145
X. Tang, H. Ren, M. Guo, J. Qian, Ye Yang, C. Gu (2021)
Review on circular RNAs and new insights into their roles in cancerComputational and Structural Biotechnology Journal, 19
Pei-long Wang, Dong Chen, Hong-bing Ma, Yong Li (2017)
LncRNA MEG3 enhances cisplatin sensitivity in non-small cell lung cancer by regulating miR-21-5p/SOX7 axisOncoTargets and therapy, 10
Lujun Chen, Yuqi Xiong, Jing Li, Xiao Zheng, Qi Zhou, A. Turner, Changping Wu, B. Lu, Jingting Jiang (2017)
PD-L1 Expression Promotes Epithelial to Mesenchymal Transition in Human Esophageal CancerCellular Physiology and Biochemistry, 42
Yamin Wang, Zhong Chen (2020)
Mutation detection and molecular targeted tumor therapies, 1
Yanyan Han, Dandan Liu, Lianhong Li (2020)
PD-1/PD-L1 pathway: current researches in cancer.American journal of cancer research, 10 3
Dong Kim, H. Kim, Yun-Jung Choi, Seon Kim, Jung-eun Lee, Ki Sung, Y. Sung, C. Pack, M. Jung, B. Han, K. Kim, W. Kim, S. Nam, Chang-Min Choi, Miyong Yun, Jae Lee, J. Rho (2019)
Exosomal PD-L1 promotes tumor growth through immune escape in non-small cell lung cancerExperimental & Molecular Medicine, 51
C. Szeto, C. Lobos, A. Nguyen, S. Gras (2020)
TCR Recognition of Peptide–MHC-I: Rule Makers and BreakersInternational Journal of Molecular Sciences, 22
Z. Hou, Yi Wang, N. Xia, T. Lv, Xiaoqin Yuan, Yong Song (2020)
Pseudogene KRT17P3 drives cisplatin resistance of human NSCLC cells by modulating miR‐497‐5p/mTORCancer Science, 112
Yuanyuan Zhou, Zhigang Hu, F. Zeng, Jiao Han (2016)
Clinical Profile of Cyclooxygenase-2 Inhibitors in Treating Non-Small Cell Lung Cancer: A Meta-Analysis of Nine Randomized Clinical TrialsPLoS ONE, 11
K. Fenchel, L. Sellmann, W. Dempke (2016)
Overall survival in non-small cell lung cancer-what is clinically meaningful?Translational lung cancer research, 5 1
Lian Zhao, Haibo Yu, Shui-Jing Yi, Xiao-wei Peng, P. Su, Zhi-ming Xiao, Rui Liu, Anliu Tang, Xiayu Li, Fen Liu, S. Shen (2016)
The tumor suppressor miR-138-5p targets PD-L1 in colorectal cancerOncotarget, 7
J. Salzman (2016)
Circular RNA Expression: Its Potential Regulation and Function.Trends in genetics : TIG, 32 5
R. Siegel, K. Miller, A. Jemal (2017)
Cancer statistics, 2017CA: A Cancer Journal for Clinicians, 67
Yaxian Zhong, Yajun Du, Xue Yang, Yongzhen Mo, Chunmei Fan, F. Xiong, Daixi Ren, Xin Ye, Chunwei Li, Yumin Wang, F. Wei, Can Guo, Xu Wu, Xiaoling Li, Yong Li, Gui-yuan Li, Zhaoyang Zeng, W. Xiong (2018)
Circular RNAs function as ceRNAs to regulate and control human cancer progressionMolecular Cancer, 17
N. Dubrawsky (1989)
Cancer statisticsCA: A Cancer Journal for Clinicians, 39
Yangxia Wang, Jinbo Liu, Jun-fen Ma, Tingyi Sun, Quanbo Zhou, Weiwei Wang, Gui-xian Wang, P. Wu, Hai-jiang Wang, Li Jiang, W. Yuan, Zhenqiang Sun, L. Ming (2019)
Exosomal circRNAs: biogenesis, effect and application in human diseasesMolecular Cancer, 18
Wenxiao Jiang, Shuya Pan, Xin Chen, Zhi-wei Wang, Xueqiong Zhu (2021)
The role of lncRNAs and circRNAs in the PD-1/PD-L1 pathway in cancer immunotherapyMolecular Cancer, 20
Hugo Gonzalez, C. Hagerling, Z. Werb (2018)
Roles of the immune system in cancer: from tumor initiation to metastatic progressionGenes & Development, 32
Botai Li, Li-Li Zhu, Chunlai Lu, Cun Wang, Hui Wang, Haojie Jin, Xuhui Ma, ZhuoAn Cheng, Chengtao Yu, Siying Wang, Q. Zuo, Yangyang Zhou, Jun Wang, Chen Yang, Yuanyuan Lv, Liyan Jiang, Wenxin Qin (2021)
circNDUFB2 inhibits non-small cell lung cancer progression via destabilizing IGF2BPs and activating anti-tumor immunityNature Communications, 12
Yunfeng Fu, Liang Huang, Hao Tang, Rong Huang (2020)
hsa_circRNA_012515 Is Highly Expressed in NSCLC Patients and Affects Its PrognosisCancer Management and Research, 12
Ashirbad Guria, Priyanka Sharma, Sankar Natesan, G. Pandi (2020)
Circular RNAs—The Road Less TraveledFrontiers in Molecular Biosciences, 6
S. Antonia, S. Goldberg, A. Balmanoukian, J. Chaft, R. Sanborn, A. Gupta, R. Narwal, K. Steele, Y. Gu, J. Karakunnel, N. Rizvi (2016)
Safety and antitumour activity of durvalumab plus tremelimumab in non-small cell lung cancer: a multicentre, phase 1b study.The Lancet. Oncology, 17 3
G. Tang, Wanqin Xie, Chuan Qin, Yunpeng Zhen, Yinlei Wang, Feiran Chen, Zhiyong Du, Zhouliang Wu, Bo Zhang, Zhonghua Shen, Dawei Tian, Hailong Hu (2017)
Expression of circular RNA circASXL1 correlates with TNM classification and predicts overall survival in bladder cancer.International journal of clinical and experimental pathology, 10 8
Jiani Dong, Zhuoer Zeng, Ruowei Sun, Xun Zhang, Zeneng Cheng, Chuanpin Chen, Qubo Zhu (2021)
Specific and sensitive detection of CircRNA based on netlike hybridization chain reaction.Biosensors & bioelectronics, 192
D. Kazandjian, D. Suzman, G. Blumenthal, Sirisha Mushti, Kun He, Meredith Libeg, P. Keegan, R. Pazdur (2016)
FDA Approval Summary: Nivolumab for the Treatment of Metastatic Non-Small Cell Lung Cancer With Progression On or After Platinum-Based ChemotherapyThe Oncologist, 21
Shuo Ma, S. Kong, Feng Wang, S. Ju (2020)
CircRNAs: biogenesis, functions, and role in drug-resistant TumoursMolecular Cancer, 19
A. Anichini, V. Perotti, F. Sgambelluri, R. Mortarini (2020)
Immune Escape Mechanisms in Non Small Cell Lung CancerCancers, 12
D. Fennell, Y. Summers, J. Cadranel, T. Benepal, D. Christoph, R. Lal, M. Das, F. Maxwell, C. Visseren-Grul, D. Ferry (2016)
Cisplatin in the modern era: The backbone of first-line chemotherapy for non-small cell lung cancer.Cancer treatment reviews, 44
Christos Miliotis, F. Slack (2021)
miR-105-5p regulates PD-L1 expression and tumor immunogenicity in gastric cancer.Cancer letters
Jian-ru Yang, Yang Jia, Bing Wang, Shengrong Yang, Kun Du, Yujie Luo, Yunhe Li, B. Zhu (2021)
Circular RNA CHST15 Sponges miR-155-5p and miR-194-5p to Promote the Immune Escape of Lung Cancer Cells Mediated by PD-L1Frontiers in Oncology, 11
B. Nicolet, Sander Engels, Francesca Aglialoro, Emile van den Akker, Marieke von Lindern, M. Wolkers (2018)
Circular RNA expression in human hematopoietic cells is widespread and cell-type specificNucleic Acids Research, 46
G. Russo, C. Proto, M. Garassino (2016)
Afatinib in the treatment of squamous non-small cell lung cancer: a new frontier or an old mistake?Translational lung cancer research, 5 1
C. D’Antonio, A. Milano, R. Righini, C. Onesti, M. Bassanelli, R. Falcone, I. Paris, S. Lauro, P. Marchetti (2014)
Pharmacogenomics in lung cancer chemotherapy: a review of what the oncologist should know.Anticancer research, 34 10
Liang Zeng, Yi-min Liu, Ning Yang, Tao Zhang, H. Xie (2021)
Hsa_circRNA_100146 Promotes Prostate Cancer Progression by Upregulating TRIP13 via Sponging miR-615-5pFrontiers in Molecular Biosciences, 8
B. Han, J. Chao, Honghong Yao (2018)
Circular RNA and its mechanisms in disease: From the bench to the clinic.Pharmacology & therapeutics, 187
Z. Çinçin, M. Unlu, B. Kiran, E. Bireller, Y. Baran, B. Çakmakoğlu (2014)
Molecular mechanisms of quercitrin-induced apoptosis in non-small cell lung cancer.Archives of medical research, 45 6
Lanxiang Huang, Y. Rong, Xuan Tang, Kezhen Yi, Jianyuan Wu, Fubing Wang (2021)
Circular RNAs Are Promising Biomarkers in Liquid Biopsy for the Diagnosis of Non-small Cell Lung CancerFrontiers in Molecular Biosciences, 8
K. Iwahori, Sunitha Kakarla, M. Velasquez, Feng Yu, Zongzhen Yi, C. Gerken, Xiao-tong Song, S. Gottschalk (2015)
Engager T cells: a new class of antigen-specific T cells that redirect bystander T cells.Molecular therapy : the journal of the American Society of Gene Therapy, 23 1
Background: Research suggests that circRNAs play important roles in non-small cell lung cancer (NSCLC). The function of hsa_circ_0068252 in NSCLC, especially in cisplatin (DDP) resistance and the mechanisms, was explored in this study. Methods: NSCLC patient samples and two NSCLC cell lines along with corresponding DDP-resistant cell lines were used. Expression levels of circ_0068252 were detected. SiRNA for circ_0068252 and inhibitor for miRNA were used in all functional analyses. A co-culture system of NSCLC cells with CD8+ T cells was used. The cellular location of circ_0068252 was detected and its target miRNA was predicted and verified. Finally, the mechanism responsible for circ_0068252 function on PD-L1 was analyzed using luciferase reporter assay in the two DDP-resistant cell lines, as well as in the co-culture system. The cytotoxicity of T cells was detected by lactate dehydrogenase assay. Results: Our findings revealed that a high level of circ_0068252 was correlated with poor prognosis of NSCLC and DDP resistance. Knockdown of circ_0068252 could promote the sensitivity of DDP-resistant NSCLC cells to DDP. Moreover, knockdown of circ_0068252 could regulate the immune microenvironment which was mediated via CD8+ T cells. Finally, circ_0068252 could up-regulate PD-L1 expression by adsorbing miR-1304-5p. Conclusion: The circ_0068252/miR-1304-5p/PD-L1 signal axis participates in the regulation of DDP resistance and immune escape of NSCLC cells. Our results suggest that circ_0068252 may be a potential diagnostic marker and therapeutic target for DDP-resistant NSCLC.
Chemotherapy – Karger
Published: Nov 1, 2022
Keywords: Circ_0068252; PD-L1; Cisplatin resistance; CircRNA; Non-small cell lung cancer
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.